Nanoparticles in Acne Treatment: Advancing Targeted Therapy and Dermatological Outcomes
Dermatology and Dermatitis · 26.03.2026 · 13 (01) · 01-05
DOI: 10.31579/2578-8949/207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology and Dermatitis, online erschienen am 26.03.2026. Verfasst von Rehan Haider * und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Acne vulgaris is a chronic inflammatory skin disorder that affects people of all ages throughout the world and produces serious physical and mental health effects. The effectiveness of standard acne treatments, which use topical retinoids, antibiotics, and benzoyl peroxide, faces multiple obstacles, which include difficulty maintaining proper skin absorption and skin discomfort, the development of antibacterial resistance, and patients' restricted ability to follow treatment plans. Researchers have discovered that nanotechnology provides a new way to solve existing problems, which lets them develop drugs that will be more effective and stable under specific situations while delivering drugs to specific targets. The therapeutic effectiveness of acne treatments has been enhanced through the use of various types of nanoparticles, which include liposomes, solid lipid nanoparticles, polymeric nanoparticles, nanoemulsions, and metallic nanoparticles. The system, which controls drug release, enables better follicular drug penetration while decreasing systemic drug distribution, which leads to greater treatment effectiveness with fewer side effects. The study investigates how nanoparticles function in acne treatment through their operational mechanisms, product development methods and their results in medical testing. The team performed a thorough review of existing literature to study how nanoparticles deliver anti-acne treatments, which include antibiotics, retinoids, and anti-inflammatory substances, along with herbal medicines. The research team examined all methodological and statistical methods that researchers used in their preclinical and clinical investigations. The studies, which researchers published, show that nanoparticles, when used in therapeutic formulas, achieve better results by decreasing inflammatory lesions, bacterial load, and sebum production than standard treatments. The discussion section describes safety issues and difficulties that arise during production at an industrial scale, and the requirements that need to be met according to regulations. The research proves that nanoparticle-based drug delivery systems enable clinicians to provide their patients with efficient acne treatments that show precise effects and cause minimal discomfort. The application of these technologies in dermatology needs both ongoing clinical investigations and the development of standardized practices.
Zitieren
APA
*, R. H., Ahmed, Z., Abbas, H., Shah, S. N., Das, G. K., & Zameer, S. (2026). Nanoparticles in Acne Treatment: Advancing Targeted Therapy and Dermatological Outcomes. Dermatology and Dermatitis, 13(01), 01-05. https://doi.org/10.31579/2578-8949/207
Vancouver
* RH, Ahmed Z, Abbas H, Shah SN, Das GK, Zameer S. Nanoparticles in Acne Treatment: Advancing Targeted Therapy and Dermatological Outcomes. Dermatology and Dermatitis. 2026;13(01):01-05. doi:10.31579/2578-8949/207
BibTeX
@article{2026,
author = {*, Rehan Haider and Ahmed, Zameer and Abbas, Hina and Shah, Shabana Naz and Das, Geetha Kumari and Zameer, Sambreen},
title = {Nanoparticles in Acne Treatment: Advancing Targeted Therapy and Dermatological Outcomes},
journal = {Dermatology and Dermatitis},
year = {2026},
volume = {13},
number = {01},
pages = {01--05},
doi = {10.31579/2578-8949/207}
}
EUVIMED